Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A rational targeted therapy for platinum-resistant small-cell lung cancer

Cancer Cell(2021)10.1016/j.ccell.2021.03.003Source: DataRank Database

A rational targeted therapy for platinum-resistant small-cell lung cancer is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.24)OA: bronzeTopics (24)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

John D. Minna ORCID,Benjamin J. Drapkin ORCID

Live enrichment

PubMed:33848475 OpenAlex:https://openalex.org/W3155406337

National Institutes of Health

Grant: 1K08CA237832-01A1

National Cancer Institute

Grant: CA213274

National Cancer Institute

Grant: CA213338

National Cancer Institute

Grant: P50CA070907

Cancer Prevention and Research Institute of Texas

Grant: RR200007

NCI NIH HHS

Grant: K08 CA237832

FWCI

0.24

Citation Percentile

0.5%

Citation Trend

2021

2023

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1535610821001616/pdf

publisherhttp://www.cell.com/article/S1535610821001616/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610821001616?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610821001616?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2021.03.003

Fields of Study

Lung Cancer Research StudiesNeuroendocrine Tumor Research AdvancesCancer therapeutics and mechanisms

MeSH Terms

Antineoplastic Combined Chemotherapy ProtocolsHumansLung NeoplasmsPlatinumTopotecan

Keywords

TopotecanCarboplatinChemotherapyEtoposideMedicineCisplatinCancer researchLung cancerOncologyCancerAtaxia-telangiectasiaInternal medicineRadiation therapyImmunologyBiologyDNA damage

Sustainable Development Goals

SDG 0: Good health and well-being